In this study, we isolated and identified the HLA-DPB1*03:01-restricted human TILs from patient’s tumor tissue that recognize natural processed and presented epitopes in KRASG12V mutants, and cloned the TCRs to construct KRASG12V-reactive TCR-engineered CD4+ T cells. This evidence concerns the gene CD4 and neoplasm.